Atea Pharmaceuticals (AVIR) Earnings Analysis
Atea Pharmaceuticals (AVIR) has no confirmed upcoming earnings date. Last quarter (2026-03-05) it missed with EPS -0.57 USD vs -0.49 USD est (-16.3%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -2.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does AVIR next report earnings?
No confirmed upcoming earnings date is currently scheduled for AVIR. This page updates as the calendar is published.
AVIR earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-05 | -0.57 USD | -0.49 USD | -16.3% | Miss |
| 2025-05-12 | -0.4 USD | -0.56 USD | +28.6% | Beat |
| 2025-03-06 | -0.4 USD | -0.35 USD | -14.3% | Miss |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
AVIR valuation and analyst view
| Trailing P/E | -2.28 |
|---|---|
| Trailing EPS | -2.14041 USD |
| Price / book | 1.63 |
| Dividend yield | 0.00% |
| Market cap | 0.38B |
| Analyst consensus | Hold (1 buy / 2 hold / 1 sell) |
| Avg price target | 10 USD |
Related research pages
Frequently asked questions
When is Atea Pharmaceuticals (AVIR)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for AVIR. This page updates as the calendar is published.
Did AVIR beat earnings last quarter?
In its 2026-03-05 report, AVIR posted EPS of -0.57 USD versus a -0.49 USD estimate — a miss of 16.3%.
What is AVIR's earnings track record?
Over the last 3 reported quarters with consensus data, AVIR beat estimates 1 times (33%).
What is AVIR's current P/E ratio and EPS?
AVIR trades at a trailing P/E of -2.28 on trailing EPS of -2.1404146993030295 USD.
What do analysts rate AVIR?
Analyst consensus is "Hold" across 4 ratings (0 strong buy, 1 buy, 2 hold, 1 sell, 0 strong sell). Average 12-month price target: 10 USD.